Thyrocare Technologies Limited has announced the closure of its trading window for Promoters, Directors, Designated Employees, and their immediate relatives. This closure will be effective from January 01, 2026. The trading window will remain closed until 48 hours after the announcement of the unaudited financial results for the quarter and nine months ended December 31, 2025, to the stock exchanges. The company will intimate the date of the Board meeting for considering these financial results in due course. This information is also available on the company's website at https://investor.thyrocare.com/
